Cost-Effectiveness of Pharmacotherapy for the Treatment of Obesity in Adolescents.

ABSTRACT:

Importance

Antiobesity pharmacotherapy is recommended for adolescents ages 12 years and older with obesity. Several medications have been approved by the US Food and Drug Administration for adolescent use, but the most cost-effective medication remains unclear.

Objective

To estimate the cost-effectiveness of lifestyle counseling alone and as adjunct to liraglutide, mid-dose phentermine and topiramate (7.5 mg phentermine and 46 mg topiramate), top-dose phentermine and topiramate (15 mg phentermine and 92 mg topiramate), or semaglutide among adolescent patients with obesity.

Design, setting, and participants

This economic evaluation used a microsimulation model to project health and cost outcomes of lifestyle counseling alone and adjunct to liraglutide, mid-dose phenter

SUBMITTER: Lim F 

PROVIDER: S-EPMC10472196 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature